Fall Term Information for Phillips Academy Families

Read More
Keith Flaherty
February 18, 2021

Dr. Keith Flaherty appointed to Phillips Academy Board of Trustees

Flaherty ’89, P’23 is director of clinical research at the Massachusetts General Hospital Cancer Center

Amy Falls ’82, P’19, ’21, president of the Phillips Academy Board of Trustees, announced today that Dr. Keith Flaherty ’89, P’23, of Cambridge, Mass., has been elected to a six-year term as a charter trustee.

A member of the Andover Bread Loaf Advisory Board since 2018, Flaherty believes deeply in the school’s mission to educate youth from every quarter and to advance education access on and beyond campus. He also recently joined the Andover Development Board and is actively engaged in the Academy’s Knowledge and Goodness Campaign.

Flaherty is director of clinical research at the Massachusetts General Hospital Cancer Center and professor of medicine at Harvard Medical School. He was appointed director of COVID-19 clinical research at MGH in March 2020.

In addition to his work to fight COVID-19, Flaherty is widely regarded for leading collaborative research to advance the treatment of melanoma. The research of Flaherty and his colleagues also has had implications for targeted therapy regimens used to treat other malignant diseases.

Flaherty’s COVID-19 teams are tasked with developing and maintaining a portfolio of the highest impact therapeutic trials. Their efforts are linked to cutting-edge diagnostic development and deployment of tools to better understand the biology of COVID-19-related complications and to better inform therapeutic development.

Among his non-profit board appointments, Flaherty joined the National Cancer Institute Board of Scientific Advisors in 2018 and American Association of Cancer Research Board of Directors in 2019. He is also editor-in-chief of Clinical Cancer Research.

Among his entrepreneurial activities, Flaherty has co-founded a number of companies, including Loxo Oncology and, most recently, Scorpion Therapeutics. He has served(s) as a director on the boards of these companies, as well as Kinnate Biopharma, Checkmate Pharmaceuticals, and Clovis Oncology.

Flaherty earned his B.S. from Yale University and his M.D. from Johns Hopkins University. He and his wife, Dr. Mira Kautzky, have two children.

Categories: Leadership

Other Stories

Dr. J. Rob Coleman ’01
Redesigning viral genomes

Dr. J. Rob Coleman ’01’s new vaccine for COVID-19 in the form of a nasal spray is on its way via Codagenix

Student award winners

Hunter Leach ’21 and Adya Chatterjee ’22 earn honors